James River Group Holdings, Ltd. (JRVR) 10-Year Financial Performance & Capital Metrics

JRVR • • Insurance & Managed Care

Financial ServicesSpecialty InsuranceSpecialty Property & Casualty InsuranceExcess & Surplus Lines Insurers

AboutJames River Group Holdings, Ltd., through its subsidiaries, provides specialty insurance and reinsurance services in the United States. It operates through Excess and Surplus Lines, Specialty Admitted Insurance, and Casualty Reinsurance segments. The Excess and Surplus Lines segment underwrites liability and property insurance on an excess and surplus commercial lines basis in all states and the District of Columbia. This segment distributes its insurance policies primarily through wholesale insurance brokers. The Specialty Admitted Insurance segment provides workers' compensation coverage for building trades, healthcare employees, goods and services, light manufacturing, specialty transportation, and agriculture, as well as fronting and program business. The Casualty Reinsurance segment offers proportional and working layer casualty reinsurance to third parties and other insurance companies. James River Group Holdings, Ltd. was founded in 2002 and is headquartered in Pembroke, Bermuda.Show more

Revenue $708M -12.9%
Combined Ratio 110.05% +23.2%
Net Income -$81M +24.7%
Return on Equity -12.74% +18.5%
Medical Cost Ratio 87.66% +24.3%
Operating Margin -10.05% -193.9%
Net Margin -11.46% +13.6%
ROA -1.57% +23.7%
Equity / Assets 11.86% -7.2%
Book Value per Share 15.36 -14.6%
Tangible BV/Share 9.82 -20.2%
Debt/Equity 0.51 +6.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Healthy dividend yield of 2.4%
✓Trading near 52-week high
✓Trading at only 0.4x book value

✗Weaknesses

✗Unprofitable underwriting: 110.1% combined ratio
✗Weak Piotroski F-Score: 2/9
✗High loss ratio of 87.7%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y4.89%

5Y-4.85%

3Y5.13%

TTM-7.34%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM70.32%

EPS CAGR

10Y-

5Y-

3Y-

TTM57.01%

ROCE

10Y Avg1.2%

5Y Avg-0.11%

3Y Avg0.46%

Latest-1.38%

Peer Comparison

Excess & Surplus Lines Insurers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AIZAssurant, Inc.	11.89B	237.45	16.42	6.7%	6.75%	14.74%	9.35%	0.41
JRVRJames River Group Holdings, Ltd.	307.51M	6.69	-2.19	-12.85%	-7.64%	-7.76%		0.51
HIPOHippo Holdings Inc.	773.74M	30.54	-18.62	77.44%	21.31%	22.75%	6.1%	0.03

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	504.92M	586.23M	817.63M	885.6M	907.13M	668.69M	609.03M	661.51M	812.01M	707.63M
Revenue Growth %	0.15%	0.16%	0.39%	0.08%	0.02%	-0.26%	-0.09%	0.09%	0.23%	-0.13%
Medical Costs & Claims+	376.77M	427.05M	671.38M	711.38M	756M	554.12M	614.06M	490.45M	572.79M	620.33M
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	128.16M	159.18M	146.25M	174.22M	151.13M	114.57M	-5.03M	171.06M	239.22M	87.29M
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	0.1%	0.24%	-0.08%	0.19%	-0.13%	-0.24%	-1.04%	35.04%	0.4%	-0.64%
Operating Expenses+	68.38M	79.84M	91.1M	103.38M	99.26M	102.63M	103.11M	117.79M	152.31M	158.41M
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	2M	2.41M	2.12M	4.21M	4.06M	5.02M	4.71M	1.05M	-475K	-709K
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	59.78M	79.34M	55.15M	70.84M	51.87M	11.94M	-108.13M	53.27M	86.91M	-71.12M
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	0.31%	0.33%	-0.3%	0.28%	-0.27%	-0.77%	-10.06%	1.49%	0.63%	-1.82%
EBITDA+	61.78M	81.76M	57.27M	75.05M	55.93M	16.96M	-103.42M	54.32M	86.44M	-71.83M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	7M	8.45M	8.97M	11.55M	10.6M	10.03M	8.92M	13.87M	24.63M	24.67M
Non-Operating Income	-7M	-8.45M	-8.97M	-11.55M	-10.6M	-10.03M	-8.92M	-13.87M	-24.63M	-24.67M
Pretax Income+	59.78M	79.34M	55.15M	70.84M	51.87M	11.94M	-108.13M	53.27M	86.91M	-71.12M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	6.28M	4.87M	11.58M	7.01M	13.53M	7.11M	-23.23M	18.41M	25.7M	-7.63M
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	53.5M	74.47M	43.57M	63.83M	38.34M	4.82M	-172.8M	30.97M	-107.68M	-81.12M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	0.2%	0.39%	-0.41%	0.47%	-0.4%	-0.87%	-36.82%	1.18%	-4.48%	0.25%
EPS (Diluted)+	1.82	2.49	1.44	2.11	1.25	0.16	-4.94	0.59	-3.13	-3.06
EPS Growth %	0.17%	0.37%	-0.42%	0.47%	-0.41%	-0.87%	-31.88%	1.12%	-6.31%	0.02%
EPS (Basic)	1.87	2.56	1.48	2.14	1.27	0.16	-4.94	0.59	-3.14	-3.06
Diluted Shares Outstanding	29.33M	29.89M	30.27M	30.31M	30.67M	30.88M	34.96M	37.65M	37.81M	38.69M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	2.06B	2.35B	2.76B	3.14B	5.02B	5.06B	4.95B	5.14B	5.32B	5.01B
Asset Growth %	0.05%	0.14%	0.17%	0.14%	0.6%	0.01%	-0.02%	0.04%	0.04%	-0.06%
Total Investment Assets+	1.24B	1.33B	1.45B	1.68B	1.99B	2.2B	2.13B	3.9B	1.71B	1.55B
Long-Term Investments	998.09M	1.07B	1.14B	1.34B	1.67B	2B	1.92B	2.01B	1.52B	1.37B
Short-Term Investments	918.93M	991.92M	1.05B	1.27B	1.59B	1.91B	1.81B	1.89B	1.4B	617.11M
Total Current Assets+	1.98M	2.97M	2.85M	2.23B	0	0	0	4.04B	0	0
Cash & Equivalents	106.41M	109.78M	163.5M	172.46M	206.91M	162.26M	190.12M	173.16M	274.3M	362.35M
Receivables	0	0	0	0	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	0	0	0	-3.05B	-3.55B	-4.12B	730.17M	-3.73B	-3.64B
Goodwill & Intangibles+	221.36M	220.76M	220.16M	219.37M	218.77M	218.23M	217.87M	217.51M	214.64M	214.28M
Goodwill	181.83M	181.83M	181.83M	181.83M	181.83M	181.83M	181.83M	181.83M	181.83M	181.83M
Intangible Assets	39.53M	38.93M	38.33M	37.54M	36.94M	36.4M	36.04M	35.68M	32.81M	32.45M
PP&E (Net)	23.99M	24.68M	25M	23.31M	1.77M	1.29M	781K	9.45M	17M	19.77M
Other Assets	-21.92M	-20.64M	-13.64M	-21.64M	-1.89B	-2.22B	-2.14B	-8.09M	-1.75B	-1.61B
Total Liabilities	1.37B	1.65B	2.06B	2.43B	4.25B	4.27B	4.22B	4.44B	4.64B	4.41B
Total Debt+	192.35M	192.35M	202.35M	222.35M	262.36M	366.36M	366.36M	326.36M	326.36M	304.86M
Net Debt	85.95M	82.57M	38.86M	49.9M	55.44M	204.09M	176.23M	153.19M	52.06M	-57.49M
Long-Term Debt	192.35M	192.35M	202.35M	222.35M	262.36M	366.36M	366.36M	326.36M	326.36M	304.86M
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Total Current Liabilities+	19.87M	39.9M	56.27M	61.66M	0	0	0	123.5M	0	0
Accounts Payable	19.87M	39.9M	56.27M	61.66M	108.06M	110.43M	135.62M	123.12M	158.67M	132.92M
Deferred Revenue	0	0	0	0	0	0	0	119.57M	0	0
Other Current Liabilities	-19.87M	-39.9M	-56.27M	-63.58M	-167.96M	-166.42M	-193.54M	-189.97M	-215.39M	-186.1M
Deferred Taxes	1000K	1000K	1000K	1000K	0	1000K	0	1000K	0	0
Other Liabilities	1.18B	1.46B	1.85B	2.21B	-262.36M	-367.46M	-366.36M	3.82B	-347.09M	-362.82M
Total Equity+	681.04M	693.22M	694.7M	709.24M	778.58M	795.61M	725.36M	698.66M	679.52M	594.03M
Equity Growth %	-0.01%	0.02%	0%	0.02%	0.1%	0.02%	-0.09%	-0.04%	-0.03%	-0.13%
Shareholders Equity	681.04M	693.22M	694.7M	709.24M	778.58M	795.61M	725.36M	698.66M	679.52M	594.03M
Minority Interest	0	0	0	0	0	0	0	0	0	0
Retained Earnings	47.03M	55.23M	48.2M	79.75M	89.59M	49.23M	-166.66M	-152.06M	-277.9M	-402.41M
Common Stock	6K	6K	6K	6K	6K	6K	7K	7K	7K	9K
Accumulated OCI	3.19M	1.13M	10.35M	-15.83M	31.11M	81.9M	29.98M	-163.04M	-63.72M	-70M
Return on Equity (ROE)	0.08%	0.11%	0.06%	0.09%	0.05%	0.01%	-0.23%	0.04%	-0.16%	-0.13%
Return on Assets (ROA)	0.03%	0.03%	0.02%	0.02%	0.01%	0%	-0.03%	0.01%	-0.02%	-0.02%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	0.28x	0.28x	0.29x	0.31x	0.34x	0.46x	0.51x	0.47x	0.48x	0.51x
Book Value per Share	23.22	23.19	22.95	23.40	25.38	25.76	20.75	18.56	17.97	15.36
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	116.39M	151.16M	207.82M	290.03M	1.49B	-273.83M	-913.55M	222.73M	87.95M	-247.09M
Operating CF Growth %	-0.11%	0.3%	0.37%	0.4%	4.13%	-1.18%	-2.34%	1.24%	-0.61%	-3.81%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	53.5M	74.47M	43.57M	63.83M	38.34M	4.82M	-172.8M	30.97M	-107.68M	-81.12M
Depreciation & Amortization	2M	2.41M	2.12M	4.21M	4.06M	5.02M	4.71M	1.05M	-475K	-709K
Stock-Based Compensation	3.73M	5.49M	7.69M	6.23M	7.18M	7.63M	6.66M	8.12M	9.12M	6.63M
Deferred Taxes	922K	5.09M	-364K	-5.86M	-4.92M	-4.42M	-20.4M	4.63M	-5.97M	-11.21M
Other Non-Cash Items	6.73M	-16.88M	-12.33M	28.66M	-7.5M	14.36M	-19.83M	39.68M	144.88M	5.49M
Working Capital Changes	49.5M	80.56M	167.13M	192.96M	1.45B	-301.24M	-711.89M	138.29M	48.09M	-166.17M
Cash from Investing+	-34.16M	-80.76M	-104.74M	-266.77M	-263.36M	-175.99M	35.82M	-328.15M	16.73M	307.03M
Capital Expenditures	0	0	0	0	-519K	-549K	-6.3M	-8.22M	-6.43M	-4.89M
Acquisitions	0	0	0	0	519K	0	0	0	0	96.41M
Purchase of Investments	-464.35M	-337.75M	-284.47M	-477.67M	-530.73M	-592.13M	-403.05M	-748.53M	-223M	-220.15M
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	38.26M	-10.18M	-37.51M	-20.53M	-4.22M	88.58M	348K	-21.68M	10.54M	10.92M
Cash from Financing+	-49.2M	-67.02M	-49.36M	-14.29M	7.96M	65.92M	147.67M	89.67M	-21.11M	-28.85M
Dividends Paid	-47.41M	-65.99M	-50.83M	-36.12M	-36.72M	-37.05M	-43.24M	-13.92M	-18.25M	-19M
Share Repurchases	-6.46M	-4.91M	-9.45M	-2.24M	-2.9M	-3.6M	0	-1.3M	-1.73M	0
Stock Issued	0	2.26M	1.71M	5.17M	0	0	192.11M	144.9M	0	12.5M
Debt Issuance (Net)	0	0	1000K	1000K	1000K	1000K	0	-1000K	0	-1000K
Other Financing	2.93M	1.62M	916K	4.07M	7.58M	2.58M	-1.2M	0	-1.14M	-847K
Net Change in Cash+	33.02M	3.38M	53.71M	8.96M	1.23B	-383.9M	-730.05M	-15.75M	83.57M	31.1M
Exchange Rate Effect	0	0	0	0	0	0	0	0	0	0
Cash at Beginning	73.38M	106.41M	109.78M	163.5M	172.46M	1.41B	1.02B	292.13M	276.38M	359.95M
Cash at End	106.41M	109.78M	163.5M	172.46M	1.41B	1.02B	292.13M	276.38M	359.95M	391.05M
Free Cash Flow+	116.39M	151.16M	207.82M	290.03M	1.49B	-274.38M	-919.85M	214.51M	81.52M	-251.97M
FCF Growth %	-0.11%	0.3%	0.37%	0.4%	4.13%	-1.18%	-2.35%	1.23%	-0.62%	-4.09%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	3.97	5.06	6.86	9.57	48.53	-8.88	-26.31	5.7	2.16	-6.51

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	88.16%	86.47%	93.26%	92%	94.28%	98.21%	117.75%	91.95%	89.3%	110.05%
Medical Cost Ratio	74.62%	72.85%	82.11%	80.33%	83.34%	82.87%	100.83%	74.14%	70.54%	87.66%
Return on Equity (ROE)	7.82%	10.84%	6.28%	9.09%	5.15%	0.61%	-22.72%	4.35%	-15.63%	-12.74%
Return on Assets (ROA)	2.67%	3.38%	1.71%	2.17%	0.94%	0.1%	-3.45%	0.61%	-2.06%	-1.57%
Equity / Assets	33.13%	29.54%	25.2%	22.61%	15.5%	15.71%	14.66%	13.6%	12.78%	11.86%
Book Value / Share	23.22	23.19	22.95	23.4	25.38	25.76	20.75	18.56	17.97	15.36
Debt / Equity	0.28x	0.28x	0.29x	0.31x	0.34x	0.46x	0.51x	0.47x	0.48x	0.51x
Revenue Growth	15.02%	16.1%	39.47%	8.31%	2.43%	-26.28%	-8.92%	8.62%	22.75%	-12.85%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Excess And Surplus Lines	240.88M	301.4M	-	555.68M	625.53M	415.17M	486M	555.6M	690.39M	594.43M
Excess And Surplus Lines Growth	-	25.13%	-	-	12.57%	-33.63%	17.06%	14.32%	24.26%	-13.90%
Specialty Admitted Insurance	42.21M	-	-	55.15M	54.34M	57.51M	75.37M	74.14M	119.78M	109.47M
Specialty Admitted Insurance Growth	-	-	-	-	-1.47%	5.83%	31.07%	-1.64%	61.56%	-8.60%
Corporate and Other	-	-	12.65M	-	-	-	-	-	1.84M	-
Corporate and Other Growth	-	-	-	-	-	-	-	-	-	-
Casualty Reinsurance	178.12M	161.98M	-	204.57M	143.88M	134.13M	134.22M	136.43M	-	-
Casualty Reinsurance Growth	-	-9.06%	-	-	-29.67%	-6.77%	0.07%	1.64%	-	-
Specialty Admitted	-	52.28M	-	-	-	-	-	-	-	-
Specialty Admitted Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

James River Group Holdings, Ltd. (JRVR) saw revenue decline by 12.9% over the past year.

James River Group Holdings, Ltd. (JRVR) reported a net loss of $49.4M for fiscal year 2024.

Dividend & Returns

Yes, James River Group Holdings, Ltd. (JRVR) pays a dividend with a yield of 2.41%. This makes it attractive for income-focused investors.

James River Group Holdings, Ltd. (JRVR) has a return on equity (ROE) of -12.7%. Negative ROE indicates the company is unprofitable.

Industry Metrics

James River Group Holdings, Ltd. (JRVR) has a combined ratio of 110.1%. A ratio above 100% means claims and expenses exceed premiums.

US Stock Screener

...

James River Group Holdings, Ltd. (JRVR) 10-Year Financial Performance & Capital Metrics

JRVR • • Insurance & Managed Care

Financial ServicesSpecialty InsuranceSpecialty Property & Casualty InsuranceExcess & Surplus Lines Insurers

Revenue $708M -12.9%
Combined Ratio 110.05% +23.2%
Net Income -$81M +24.7%
Return on Equity -12.74% +18.5%
Medical Cost Ratio 87.66% +24.3%
Operating Margin -10.05% -193.9%
Net Margin -11.46% +13.6%
ROA -1.57% +23.7%
Equity / Assets 11.86% -7.2%
Book Value per Share 15.36 -14.6%
Tangible BV/Share 9.82 -20.2%
Debt/Equity 0.51 +6.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Healthy dividend yield of 2.4%
✓Trading near 52-week high
✓Trading at only 0.4x book value

✗Weaknesses

✗Unprofitable underwriting: 110.1% combined ratio
✗Weak Piotroski F-Score: 2/9
✗High loss ratio of 87.7%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y4.89%

5Y-4.85%

3Y5.13%

TTM-7.34%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM70.32%

EPS CAGR

10Y-

5Y-

3Y-

TTM57.01%

ROCE

10Y Avg1.2%

5Y Avg-0.11%

3Y Avg0.46%

Latest-1.38%

Peer Comparison

Excess & Surplus Lines Insurers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AIZAssurant, Inc.	11.89B	237.45	16.42	6.7%	6.75%	14.74%	9.35%	0.41
JRVRJames River Group Holdings, Ltd.	307.51M	6.69	-2.19	-12.85%	-7.64%	-7.76%		0.51
HIPOHippo Holdings Inc.	773.74M	30.54	-18.62	77.44%	21.31%	22.75%	6.1%	0.03

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	504.92M	586.23M	817.63M	885.6M	907.13M	668.69M	609.03M	661.51M	812.01M	707.63M
Revenue Growth %	0.15%	0.16%	0.39%	0.08%	0.02%	-0.26%	-0.09%	0.09%	0.23%	-0.13%
Medical Costs & Claims+	376.77M	427.05M	671.38M	711.38M	756M	554.12M	614.06M	490.45M	572.79M	620.33M
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	128.16M	159.18M	146.25M	174.22M	151.13M	114.57M	-5.03M	171.06M	239.22M	87.29M
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	0.1%	0.24%	-0.08%	0.19%	-0.13%	-0.24%	-1.04%	35.04%	0.4%	-0.64%
Operating Expenses+	68.38M	79.84M	91.1M	103.38M	99.26M	102.63M	103.11M	117.79M	152.31M	158.41M
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	2M	2.41M	2.12M	4.21M	4.06M	5.02M	4.71M	1.05M	-475K	-709K
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	59.78M	79.34M	55.15M	70.84M	51.87M	11.94M	-108.13M	53.27M	86.91M	-71.12M
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	0.31%	0.33%	-0.3%	0.28%	-0.27%	-0.77%	-10.06%	1.49%	0.63%	-1.82%
EBITDA+	61.78M	81.76M	57.27M	75.05M	55.93M	16.96M	-103.42M	54.32M	86.44M	-71.83M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	7M	8.45M	8.97M	11.55M	10.6M	10.03M	8.92M	13.87M	24.63M	24.67M
Non-Operating Income	-7M	-8.45M	-8.97M	-11.55M	-10.6M	-10.03M	-8.92M	-13.87M	-24.63M	-24.67M
Pretax Income+	59.78M	79.34M	55.15M	70.84M	51.87M	11.94M	-108.13M	53.27M	86.91M	-71.12M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	6.28M	4.87M	11.58M	7.01M	13.53M	7.11M	-23.23M	18.41M	25.7M	-7.63M
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	53.5M	74.47M	43.57M	63.83M	38.34M	4.82M	-172.8M	30.97M	-107.68M	-81.12M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	0.2%	0.39%	-0.41%	0.47%	-0.4%	-0.87%	-36.82%	1.18%	-4.48%	0.25%
EPS (Diluted)+	1.82	2.49	1.44	2.11	1.25	0.16	-4.94	0.59	-3.13	-3.06
EPS Growth %	0.17%	0.37%	-0.42%	0.47%	-0.41%	-0.87%	-31.88%	1.12%	-6.31%	0.02%
EPS (Basic)	1.87	2.56	1.48	2.14	1.27	0.16	-4.94	0.59	-3.14	-3.06
Diluted Shares Outstanding	29.33M	29.89M	30.27M	30.31M	30.67M	30.88M	34.96M	37.65M	37.81M	38.69M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	2.06B	2.35B	2.76B	3.14B	5.02B	5.06B	4.95B	5.14B	5.32B	5.01B
Asset Growth %	0.05%	0.14%	0.17%	0.14%	0.6%	0.01%	-0.02%	0.04%	0.04%	-0.06%
Total Investment Assets+	1.24B	1.33B	1.45B	1.68B	1.99B	2.2B	2.13B	3.9B	1.71B	1.55B
Long-Term Investments	998.09M	1.07B	1.14B	1.34B	1.67B	2B	1.92B	2.01B	1.52B	1.37B
Short-Term Investments	918.93M	991.92M	1.05B	1.27B	1.59B	1.91B	1.81B	1.89B	1.4B	617.11M
Total Current Assets+	1.98M	2.97M	2.85M	2.23B	0	0	0	4.04B	0	0
Cash & Equivalents	106.41M	109.78M	163.5M	172.46M	206.91M	162.26M	190.12M	173.16M	274.3M	362.35M
Receivables	0	0	0	0	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	0	0	0	-3.05B	-3.55B	-4.12B	730.17M	-3.73B	-3.64B
Goodwill & Intangibles+	221.36M	220.76M	220.16M	219.37M	218.77M	218.23M	217.87M	217.51M	214.64M	214.28M
Goodwill	181.83M	181.83M	181.83M	181.83M	181.83M	181.83M	181.83M	181.83M	181.83M	181.83M
Intangible Assets	39.53M	38.93M	38.33M	37.54M	36.94M	36.4M	36.04M	35.68M	32.81M	32.45M
PP&E (Net)	23.99M	24.68M	25M	23.31M	1.77M	1.29M	781K	9.45M	17M	19.77M
Other Assets	-21.92M	-20.64M	-13.64M	-21.64M	-1.89B	-2.22B	-2.14B	-8.09M	-1.75B	-1.61B
Total Liabilities	1.37B	1.65B	2.06B	2.43B	4.25B	4.27B	4.22B	4.44B	4.64B	4.41B
Total Debt+	192.35M	192.35M	202.35M	222.35M	262.36M	366.36M	366.36M	326.36M	326.36M	304.86M
Net Debt	85.95M	82.57M	38.86M	49.9M	55.44M	204.09M	176.23M	153.19M	52.06M	-57.49M
Long-Term Debt	192.35M	192.35M	202.35M	222.35M	262.36M	366.36M	366.36M	326.36M	326.36M	304.86M
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Total Current Liabilities+	19.87M	39.9M	56.27M	61.66M	0	0	0	123.5M	0	0
Accounts Payable	19.87M	39.9M	56.27M	61.66M	108.06M	110.43M	135.62M	123.12M	158.67M	132.92M
Deferred Revenue	0	0	0	0	0	0	0	119.57M	0	0
Other Current Liabilities	-19.87M	-39.9M	-56.27M	-63.58M	-167.96M	-166.42M	-193.54M	-189.97M	-215.39M	-186.1M
Deferred Taxes	1000K	1000K	1000K	1000K	0	1000K	0	1000K	0	0
Other Liabilities	1.18B	1.46B	1.85B	2.21B	-262.36M	-367.46M	-366.36M	3.82B	-347.09M	-362.82M
Total Equity+	681.04M	693.22M	694.7M	709.24M	778.58M	795.61M	725.36M	698.66M	679.52M	594.03M
Equity Growth %	-0.01%	0.02%	0%	0.02%	0.1%	0.02%	-0.09%	-0.04%	-0.03%	-0.13%
Shareholders Equity	681.04M	693.22M	694.7M	709.24M	778.58M	795.61M	725.36M	698.66M	679.52M	594.03M
Minority Interest	0	0	0	0	0	0	0	0	0	0
Retained Earnings	47.03M	55.23M	48.2M	79.75M	89.59M	49.23M	-166.66M	-152.06M	-277.9M	-402.41M
Common Stock	6K	6K	6K	6K	6K	6K	7K	7K	7K	9K
Accumulated OCI	3.19M	1.13M	10.35M	-15.83M	31.11M	81.9M	29.98M	-163.04M	-63.72M	-70M
Return on Equity (ROE)	0.08%	0.11%	0.06%	0.09%	0.05%	0.01%	-0.23%	0.04%	-0.16%	-0.13%
Return on Assets (ROA)	0.03%	0.03%	0.02%	0.02%	0.01%	0%	-0.03%	0.01%	-0.02%	-0.02%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	0.28x	0.28x	0.29x	0.31x	0.34x	0.46x	0.51x	0.47x	0.48x	0.51x
Book Value per Share	23.22	23.19	22.95	23.40	25.38	25.76	20.75	18.56	17.97	15.36
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	116.39M	151.16M	207.82M	290.03M	1.49B	-273.83M	-913.55M	222.73M	87.95M	-247.09M
Operating CF Growth %	-0.11%	0.3%	0.37%	0.4%	4.13%	-1.18%	-2.34%	1.24%	-0.61%	-3.81%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	53.5M	74.47M	43.57M	63.83M	38.34M	4.82M	-172.8M	30.97M	-107.68M	-81.12M
Depreciation & Amortization	2M	2.41M	2.12M	4.21M	4.06M	5.02M	4.71M	1.05M	-475K	-709K
Stock-Based Compensation	3.73M	5.49M	7.69M	6.23M	7.18M	7.63M	6.66M	8.12M	9.12M	6.63M
Deferred Taxes	922K	5.09M	-364K	-5.86M	-4.92M	-4.42M	-20.4M	4.63M	-5.97M	-11.21M
Other Non-Cash Items	6.73M	-16.88M	-12.33M	28.66M	-7.5M	14.36M	-19.83M	39.68M	144.88M	5.49M
Working Capital Changes	49.5M	80.56M	167.13M	192.96M	1.45B	-301.24M	-711.89M	138.29M	48.09M	-166.17M
Cash from Investing+	-34.16M	-80.76M	-104.74M	-266.77M	-263.36M	-175.99M	35.82M	-328.15M	16.73M	307.03M
Capital Expenditures	0	0	0	0	-519K	-549K	-6.3M	-8.22M	-6.43M	-4.89M
Acquisitions	0	0	0	0	519K	0	0	0	0	96.41M
Purchase of Investments	-464.35M	-337.75M	-284.47M	-477.67M	-530.73M	-592.13M	-403.05M	-748.53M	-223M	-220.15M
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	38.26M	-10.18M	-37.51M	-20.53M	-4.22M	88.58M	348K	-21.68M	10.54M	10.92M
Cash from Financing+	-49.2M	-67.02M	-49.36M	-14.29M	7.96M	65.92M	147.67M	89.67M	-21.11M	-28.85M
Dividends Paid	-47.41M	-65.99M	-50.83M	-36.12M	-36.72M	-37.05M	-43.24M	-13.92M	-18.25M	-19M
Share Repurchases	-6.46M	-4.91M	-9.45M	-2.24M	-2.9M	-3.6M	0	-1.3M	-1.73M	0
Stock Issued	0	2.26M	1.71M	5.17M	0	0	192.11M	144.9M	0	12.5M
Debt Issuance (Net)	0	0	1000K	1000K	1000K	1000K	0	-1000K	0	-1000K
Other Financing	2.93M	1.62M	916K	4.07M	7.58M	2.58M	-1.2M	0	-1.14M	-847K
Net Change in Cash+	33.02M	3.38M	53.71M	8.96M	1.23B	-383.9M	-730.05M	-15.75M	83.57M	31.1M
Exchange Rate Effect	0	0	0	0	0	0	0	0	0	0
Cash at Beginning	73.38M	106.41M	109.78M	163.5M	172.46M	1.41B	1.02B	292.13M	276.38M	359.95M
Cash at End	106.41M	109.78M	163.5M	172.46M	1.41B	1.02B	292.13M	276.38M	359.95M	391.05M
Free Cash Flow+	116.39M	151.16M	207.82M	290.03M	1.49B	-274.38M	-919.85M	214.51M	81.52M	-251.97M
FCF Growth %	-0.11%	0.3%	0.37%	0.4%	4.13%	-1.18%	-2.35%	1.23%	-0.62%	-4.09%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	3.97	5.06	6.86	9.57	48.53	-8.88	-26.31	5.7	2.16	-6.51

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	88.16%	86.47%	93.26%	92%	94.28%	98.21%	117.75%	91.95%	89.3%	110.05%
Medical Cost Ratio	74.62%	72.85%	82.11%	80.33%	83.34%	82.87%	100.83%	74.14%	70.54%	87.66%
Return on Equity (ROE)	7.82%	10.84%	6.28%	9.09%	5.15%	0.61%	-22.72%	4.35%	-15.63%	-12.74%
Return on Assets (ROA)	2.67%	3.38%	1.71%	2.17%	0.94%	0.1%	-3.45%	0.61%	-2.06%	-1.57%
Equity / Assets	33.13%	29.54%	25.2%	22.61%	15.5%	15.71%	14.66%	13.6%	12.78%	11.86%
Book Value / Share	23.22	23.19	22.95	23.4	25.38	25.76	20.75	18.56	17.97	15.36
Debt / Equity	0.28x	0.28x	0.29x	0.31x	0.34x	0.46x	0.51x	0.47x	0.48x	0.51x
Revenue Growth	15.02%	16.1%	39.47%	8.31%	2.43%	-26.28%	-8.92%	8.62%	22.75%	-12.85%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Excess And Surplus Lines	240.88M	301.4M	-	555.68M	625.53M	415.17M	486M	555.6M	690.39M	594.43M
Excess And Surplus Lines Growth	-	25.13%	-	-	12.57%	-33.63%	17.06%	14.32%	24.26%	-13.90%
Specialty Admitted Insurance	42.21M	-	-	55.15M	54.34M	57.51M	75.37M	74.14M	119.78M	109.47M
Specialty Admitted Insurance Growth	-	-	-	-	-1.47%	5.83%	31.07%	-1.64%	61.56%	-8.60%
Corporate and Other	-	-	12.65M	-	-	-	-	-	1.84M	-
Corporate and Other Growth	-	-	-	-	-	-	-	-	-	-
Casualty Reinsurance	178.12M	161.98M	-	204.57M	143.88M	134.13M	134.22M	136.43M	-	-
Casualty Reinsurance Growth	-	-9.06%	-	-	-29.67%	-6.77%	0.07%	1.64%	-	-
Specialty Admitted	-	52.28M	-	-	-	-	-	-	-	-
Specialty Admitted Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

James River Group Holdings, Ltd. (JRVR) saw revenue decline by 12.9% over the past year.

James River Group Holdings, Ltd. (JRVR) reported a net loss of $49.4M for fiscal year 2024.

Dividend & Returns

Yes, James River Group Holdings, Ltd. (JRVR) pays a dividend with a yield of 2.41%. This makes it attractive for income-focused investors.

James River Group Holdings, Ltd. (JRVR) has a return on equity (ROE) of -12.7%. Negative ROE indicates the company is unprofitable.

Industry Metrics

James River Group Holdings, Ltd. (JRVR) has a combined ratio of 110.1%. A ratio above 100% means claims and expenses exceed premiums.